Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Surgery|July 30, 2009
Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centersLarissa K Temple, Dorothy Romanus, Joyce Niland, et al.European Journal of Haematology|May 18, 2020
Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United KingdomMohamad Mohty, Wolfgang Knauf, Dorothy Romanus, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysisDorothy Romanus, Martin R Weiser, John M Skibber, et al.Expert Review of Hematology|March 10, 2020
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRdAjai Chari, Paul G Richardson, Dorothy Romanus, et al.Blood Cancer Journal|November 11, 2018
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world settingPaul G Richardson, Jesus F San Miguel, Philippe Moreau, et al.Future Oncology (London, England)|August 3, 2021
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in SpainJosé-Ángel Hernández-Rivas, Mario Arnao, José Maria Arguiñano Pérez, et al.Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.Annals of Hematology|May 10, 2021
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the USFaith Davies, Robert Rifkin, Caitlin Costello, et al.Pageof 3